Abstract
Whether or not T cell receptor engagement leads to full activation or tolerance is determined by the context in which the antigen is encountered. Antigen presented by activated APCs in the presence of costimulation leads to full T cell activation, while antigen presented by resting APCs leads to tolerance. Pathogen-associated molecular patterns in the form of toll-like receptor ligands play a critical role in activating APCs and promoting T cell activation. In this review we hypothesize that low-molecular-weight species of the extracellular matrix polymer hyaluronan also performs this function by acting as an endogenous danger signal.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schwartz RH: Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065.
Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233.
Janeway, CA Jr: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54Pt 1:1.
Medzhitov R, Janeway C Jr: Innate immunity. N Engl J Med 2000;343:338.
Medzhitov R, Janeway CA Jr: How does the immune system distinguish self from nonself? Semin Immunol 2000;12:185.
Fuchs EJ, Matzinger P: Is cacer dangerous to the immune system? Semin Immunol 1996;8:271.
Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991.
Matzinger P: The danger model: a renewed sense of self. Science 2002;296:301.
Gallucci S, Matzinger P: Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114.
Shi Y, Evans JE, Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516.
Laurent T, Fraser J: Hyaluronan. FASEB J 1992;6:2397.
Laurent TC: Functions of hyaluronan. A Rheum Dis 1995;54:429.
Hance AJ, Crystal RG: The connective tissue of lung. Am Rev Resp Dis 1975;112:657.
Sampson P, Rochester C, Freundlich B, Elias J: Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest 1992;90:1492.
Bjermer L, Eklund A, Blaschke E: Bronchoalveolar lavage fibronectin in patients with sarcoidosis: correlation to hyaluronan and disease activity. Eur Resp J 1991;4:965.
Hallgren R, Eklund A, Engstrom-Laurent B, Schmekel B: Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J 1985;290:1778.
Terneer CC, Hennies J, Voith U, et al: Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863.
McKee C, Penno M, Cowman M, et al: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996;98:2403.
McKee C, Lowenstein C, Horton M, et al: Hyaluronan fragments induce nitric oxide in murine macrophages through an NF-κB-dependent mechanism. J Biol Chem 1997;272:8013.
Horton MR, McKee CM, Bao C, et al: Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 1998;52:35088.
Horton MR, Shapiro S, Bao C, Lowenstein CJ, Nobte PW. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 1999;162:4171.
Horton MR, Olman MA, Bao C, et al: Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol 2000;279:L707.
Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW: Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J Immunol 1998;160:3023.
Hodge-Dufour J, Noble PW, Horton MR, et al: Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997;15:2492.
Hodge-Dufour J, Marino MW, Horton MR, et al: Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci USA 1998;95:13806.
Schawalder A, Oertli B, Beck-Schimmer B, Wuthrich RP: Regulation of hyaluronan-stimulated VCAM-1 expression i murine renal tubular epithelial cells. Nephrol Dial Transplant 1999;14:2130.
Sun LK, Beck-Schimmer B, Oertli B, Wuthrich RP: Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells. Kidney Int 2001;59:190.
Beck-Schimmer B, Oertli B, Pasch T, Wuthrich RP: Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol 1998;9:2283.
Mascarenhas MM, Day RM, Ochoa CD, et al: Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am J Respir Cell Mol Biol 2004;30:51.
Hamilton LM, Davies DE, Wilson SJ, Kimber I, Dearman RJ, Holgate ST. The bronchial epithelium in asthma—much more than a passive barrier. Monaldi Arch Chest Dis 2001;56:48.
Oudin S, Pugin J: Role of MAP kinase activation in interleukin-8 production by human BEAS-2B bronchial epithelial cells submitted to cyclic stretch. Am J Respir Cell Mol Biol 2002;27:107.
Humbert M: Airways inflammation in asthma and chronic bronchitis. Clin Exp Allergy 1996;26:735.
Laurent TC, Fraser JR, Laurent UB, Engstrom-Laurent A: Hyaluronan in inflammatory joint, disease. Acta Orthop Scand Suppl 1995;266116.
Noble PW: Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002;21:25.
Reise Sousa C: Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 2004;16:21.
Reise Sousa C: Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004;16:27.
Termeer C, Benedix F, Sleeman J, et al: Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99.
Termeer C, Johannsen H, Braun T, et al: The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation. J Leukoc Biol 2001;70:715.
Mummert DI, Takashima A, Ellinger L, Mummert ME: Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo. J Dermatol Sci 2003;33:91.
Schall TJ: The chemokines in Thomson AW (ed.). The Cytokine Handbook. London, Academic Press, p. 419.
Park MK, Amichay D, Love P, et al.: The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J Immunol 2002;169:1433.
Godiska R, Chantry D, Dietsch GN, Gray PW: Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 1995;58:167.
Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD: An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 1995;155:5003.
Horton MR, Boodoo S, Powell JD: NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J Biol Chem 2002;277:43757.
Farber JM: A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factof 4 family of cytokines. Proc Natl Acad Sci USA 1990;87:5238.
Farber JM: A collection of mRNA species that are inducible in the RAW, 264.7 mouse macrophage cell line by gamma interferon and other agents. Mol Cell Biol 1992;12:1535.
Farber JM: HuMIG: a new mwmber of the chemokine family of cytokines. Biochem Biophys Res Commun 1993;192:223.
Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM: Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995;182:1301.
Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL: The role of CXC chemokines as regulators of angiogenesis. Shock 1995;4:155.
Yun JJ, Fischbein MP, Whiting D, et al: The role of MIG/CXCL 9 in cardiac allograft vasculopathy/Am J Pathol 2002;161:1307.
Belperio JA, Keane MB, Burdick MD, et al: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002;169:1037.
Mahad DJ, Howell SJ, Woodroofe MN: Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:498.
Liu MT, Armstrong D, Hamilton TA, Lane TE: Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 2001;166:1790.
Kohda D, Morton CJ, Parkar AA, et al: Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 1996;86:767.
Takeda M, Terasawa H, Sakakura M, et al: Hyaluronan recognition mode of CD44 revealed by cross-saturation and chemical shift perturbation experiments. J Biol Chem 2003;278:43550.
Banerji S, Ni J, Wang SX, et al: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789.
Hall CL, Wang C, Lange LA, Turley EA: Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994;126:575.
Hall CL, Yang B, Yang X, et al: Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995;82:19.
Maxwell CA, Keats JJ, Crainie M, et al: RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol Biol Cell 2003;14:2262.
Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NF-κB/lκBα autoregulatory loop in murine macrophages. J Exp Med 1996;183:2373.
Fitzgerald KA, Bowie AG, Skeffington BS, O'Neill LA: Ras, protein kinase C zeta, and I kappa B kinases I and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. J Immunol 2000;164:2053.
Manicourt DH, Poilvache P, Nzeusseu A, et al: Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest. Arthritis Rheum 1999;42:1861.
Shigemori M, Takei S, Imanaka H, Maeno N, Hokonohara M, Miyata K: Diagnostic significance of increased serum hyaluronic acid in juvenile rheumatoid arthritis. Pediatr Int 2002;44:394.
Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D: Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin Rheumatol 2000;19:455.
Kubo M, Kikuchi K, Yazawa N, Fujimoto M, Tamaki T, Tamaki K: Increased serum concentration of hyaluronate in dermatomyositis patients. Arch Dermatol Res 1998;290:579.
Song WD, Zhang AC, Pang YY, et al: Fibronectin and hyaluronan in bronchoalveolar lavage fluid from young patients with chronic obstructive, pulmonary diseases. Respiration 1995;62:125.
Tufveson G, Gerdin B, Larsson E, et al.: Hyaluronic acid accumulation; the mechanism behind graft rejection edema. Transpl Int 1992;5(Suppl 1):S688.
Bowden DH: Unraveling pulmonary fibrosis: the bleomycin model. Lab Invest 1984;50:487.
Teder P, Vandivier RW, Jiang D, et al: Resolution of lung inflammation by CD44. Science 2002;296:155.
Wang JY, Roehrl MH: Glycosaminoglycans are a potential cause of rheumatoid arthritis. Proc Natl Acad Sci USA 2002;99:14362.
Goto M, Hanyu T, Yoshio T, et al.: Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol 2001;19:377.
Cantor JO, Cerreta JM, Armand G, Turino GM: Further investigation of the use of intratracheally administered hyaluronic acid to ameliorate elastase-induced emphysema. Exp Lung Res 1997;23:229.
Noble P, Lake F, Henson P, Riches D: Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor- α-dependent mechanism in murine macrophages. J Clin Invest 1993;91:2368.
Yang T, Witham TF, Villa L, et al: Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Cancer Res 2002;62:2583.
Singleton PA, Bourguignon LY: CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp Cell Res 2004;295:102.
Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL: Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol Chem 2004;279:17079.
Lokeshwar VB, Selzer MG: Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 2000;275:27641.
Chajara A, Raoudi M, Delpech B, Levesque H: Inhibition of arterial cells proliferation in vivo in injured arteries by hyaluronan fragments. Atherosclerosis 2003;171:15.
Wang MJ, Jeng KC, Kuo JS, et al: c-Jun N-terminal kinase and, to a lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated BV-2 microglia. J Neuroimmunol 2004;146:50.
Fieber C, Baumann P, Vallon R, et al: Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci 2004;117:359.
Haslinger B, Mandl-Weber S, Sellmayer A, Sitter T: Hyaluronan fragments induce, the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res 2001;305:79.
Rockey DC, Chung JJ, McKee CM, Noble PW: Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 1998;27:86.
Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T: CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Int J Cancer 2002;102:379.
Ghatak S, Misra S, Toole BP: Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002;277:38013.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Powell, J.D., Horton, M.R. Threat matrix. Immunol Res 31, 207–218 (2005). https://doi.org/10.1385/IR:31:3:207
Issue Date:
DOI: https://doi.org/10.1385/IR:31:3:207